IntelliPharmaCeutics International Inc. Share Price OTC Bulletin Board
Equities
CA4581733090
Pharmaceuticals
Sales 2021 | - | Sales 2022 | 65.73T 54.9L | Capitalization | 24.67L 21Cr |
---|---|---|---|---|---|
Net income 2021 | -50L -42Cr | Net income 2022 | -20L -17Cr | EV / Sales 2021 | - |
Net Debt 2021 | 11.45L 9.57Cr | Net Debt 2022 | 22.42L 19Cr | EV / Sales 2022 | 71.6 x |
P/E ratio 2021 |
-0.65
x | P/E ratio 2022 |
-0.85
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.24% |
Managers | Title | Age | Since |
---|---|---|---|
Amina Odidi
FOU | Founder | - | 01/98/01 |
Isa Odidi
CEO | Chief Executive Officer | - | 01/98/01 |
Comptroller/Controller/Auditor | - | 01/07/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Betts
BRD | Director/Board Member | 69 | 22/19/22 |
Isa Odidi
CEO | Chief Executive Officer | - | 01/98/01 |
Amina Odidi
FOU | Founder | - | 01/98/01 |
1st Jan change | Capi. | |
---|---|---|
+50.70% | 79TCr | |
+41.96% | 63TCr | |
-7.15% | 35TCr | |
+18.77% | 33TCr | |
+8.79% | 30TCr | |
+18.02% | 25TCr | |
+1.27% | 22TCr | |
+11.95% | 22TCr | |
+3.68% | 16TCr |